SCHEMBL9091041

SCHEMBL9091041

CC(C)(C)[Si](C)(C)OCC#Cc1nc(C#N)c(C#N)nc1C#CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9092968 0.74 PGK1 (0.36) —
SCHEMBL2168948 0.73 — —
SCHEMBL2901795 0.69 — —
SCHEMBL20973025 0.69 — —
SCHEMBL8526099 0.68 CYP1A2 (0.41) —
SCHEMBL336316 0.68 — —
SCHEMBL30087109 0.68 HPGDS (0.30) —
SCHEMBL27176907 0.68 HPGDS (0.30) —
SCHEMBL23043878 0.67 KDM4E (0.34) —
SCHEMBL2160545 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583227-A INHIBIT SECRETION OF GASTRIC ACID MOCHIDA PHARMACEUTICAL CO. LTD. (JP) 1996-12-10 — — US disclosed
EP-0685468-A1 Pyrazine and quinoxaline derivatives and their use as anti-ulcer agents Mochida Pharmaceutical Co., Ltd. (JP) 1995-12-06 — — EP disclosed
Send feedback